ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neutrophils"

  • Abstract Number: 0693 • ACR Convergence 2022

    Low Neutrophil Ectonucleotidase Activity Drives Neutrophil-Platelet Aggregation and Platelet Activation in Antiphospholipid Syndrome (APS)

    Naveen Kumar S K1, Claire Hoy1, Srilakshmi Yalavarthi1, Cyrus Sarosh2, Kaitlyn Sabb1, Christine Rysenga1, Jacqueline Madison1, Yu Zuo1 and Jason S Knight3, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Temperance, MI, 3University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: By converting extracellular ATP into homeostatic adenosine, the ectonucleotidases CD39 (ATP to AMP) and CD73 (AMP to adenosine) dictate extracellular purinergic gradients and as…
  • Abstract Number: 2269 • ACR Convergence 2022

    Anti-NET Antibodies in Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Yu (Ray) Zuo1, Sherwin Navaz1, Alex Tsodikov1, Katarina Kmetova2, Claire Hoy1, Srilakshmi Yalavarthi1, Danieli Castro Oliveira de Andrade3, Maria G. Tektonidou4, Savino Sciascia5, Vittorio Pengo6, Guillermo Ruiz-Irastorza7, H Michael Belmont8, maria gerosa9, Paul fortin10, Guilherme de Jesús11, D. Ware Branch12, Laura Andreoli13, Esther Rodriguez Almaraz14, Michelle Petri15, Ricard Cervera16, Rohan Willis17, Doruk Erkan18 and Jason S Knight19, 1University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 4National and Kapodistrian University of Athens, Athens, Greece, 5University of Turin, Torino, Italy, 6Padova University Hospital, Padova, Italy, 7Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain, 8NYU School of Medicine, New York, NY, 9University of Milan, Milano, Italy, 10CHU de Québec, Pavillon CHUL, Québec, Canada, 11Universidade do Estado do Rio de Janeiro, Rio De Janeiro, Brazil, 12University of Utah, Salt Lake City, UT, 13Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 14Hospital Universitario 12 de Octubre, Madrid, Spain, 15Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 16Hospital Clínic de Barcelona, Barcelona, Spain, 17University of Texas Medical Branch, Galveston, TX, 18Hospital for Special Surgery, New York, NY, 19University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils plays a role in the thromboinflammatory phenotype of APS. Previous work has demonstrated that…
  • Abstract Number: 0877 • ACR Convergence 2022

    Neutrophils Extracellular Traps Formation May Serve as a Biomarker for Disease Activity in Oligoarticular Juvenile Idiopathic Arthritis

    Merav Heshin-Bekenstein1, Szilvia Baron2, Grant Schulert3, Anna Shusterman4, Rachel Shukrun4, Yoav Binenbaum4 and Ronit Elhasid5, 1Dana Dwek Children's Hospital, Tel Aviv Medical Center Israel, Binyamina, Israel, 2Pediatric Hemato-Oncology Research Laboratory, Tel Aviv Medical Center, Tel Aviv, Israel, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Tel Aviv Medical Center, Tel Aviv, Israel, 5Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv, Israel

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, causing significant morbidity. Despite the dramatic improvement in treatment, many patients…
  • Abstract Number: 2271 • ACR Convergence 2022

    Circulating Calprotectin: A Potential New Biomarker for “Non-Criteria” Clinical Manifestations of Antiphospholipid Syndrome

    Claire Hoy1, Naveen Kumar S K1, Sherwin Navaz1, Srilakshmi Yalavarthi1, Cyrus Sarosh2, Noah Peters1, Tristin Smith1, Gary Norman3, Gabriel Figueroa Parra4, Johann Gudjonsson1, J. Michelle Kahlenberg1, Jacqueline Madison1, Ali Duarte-Garcia4, Jason S Knight5 and Yu (Ray) Zuo1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Temperance, MI, 3INOVA Diagnostics, San Diego, CA, 4Mayo Clinic, Rochester, MN, 5University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: While thrombosis and pregnancy loss are the best-known features of APS, many patients also exhibit "non-criteria" manifestations such as thrombocytopenia and heart valve damage.…
  • Abstract Number: 0045 • ACR Convergence 2022

    Rheumatoid Arthritis Patient-derived Anti-citrullinated Protein Antibodies (ACPAs) Ameliorate Joint Inflammation in Early Collagen-antibody Induced Arthritis (CAIA)

    Alejandro Gomez1, Camille Brewer1, Jae-Seung Moon2, Suman Acharya1, Tobias V. Lanz1, Qian Wang1, Gundula Min-Oo3, Anita Niedziela-Majka3 and William Robinson4, 1Stanford University, Stanford, CA, 2Stanford University, Palo Alto, CA, 3Gilead Sciences, Foster City, CA, 4Stanford University School of Medicine, Palo Alto, CA

    Background/Purpose: ACPAs are present in two-thirds of patients with rheumatoid arthritis (RA) and are associated with higher risks for severe bone erosions. The pathogenic role…
  • Abstract Number: 1156 • ACR Convergence 2022

    Serum Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Is Increased in Patients with Active Ankylosing Spondylitis (AS) and Persists Despite Anti-TNF Treatment

    Charalampos Papagoras1, Styliani Tsiami2, Akrivi Chrysanthopoulou1, Ioannis Mitroulis1 and Xenofon Baraliakos3, 1First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, 2Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: There is increasing evidence of the pathogenetic role of monocytes and neutrophils in AS, while the neutrophil-to-lymphocyte ratio correlates with disease activity (1). Granulocyte-Monocyte…
  • Abstract Number: 0049 • ACR Convergence 2022

    IL-18 Receptor-α Signaling Pathway Contributes to Autoantibody-induced Arthritis via Neutrophil Recruitment

    Shinjiro Kaieda and Tomoaki Hoshino, Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: We have previously reported that IL-18 levels in the lungs, serum and bronchoalveolar lavage fluid (BALF) were increased in patients with idiopathic pulmonary lung…
  • Abstract Number: 1321 • ACR Convergence 2022

    Systemic Inflammatory-based Scores and Bone Turnover Ratio as Novel Diagnostic Tools for Chronic Nonbacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region in Adults

    Anne Leerling, Juliette Faber, Natasha Appelman-Dijkstra, Olaf Dekkers and Elizabeth Winter, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: Chronic non-bacterial osteomyelitis (CNO) in adults exhibits as sterile osteitis and consequent disrupted bone metabolism favoring bone formation of the sternocostoclavicular region (SCCH). Diagnosis…
  • Abstract Number: 0053 • ACR Convergence 2022

    Natural Microbial Exposure Increases Susceptibility of C57BL/6 Mice to Collagen-induced Arthritis

    Sahar Lotfi-Emran1 and David Masopust2, 1University of Minnesota, Minneapolis, MN, 2University of Minnesota, Department of Microbiology and Immunology, Minneapolis, MN

    Background/Purpose: Mice exposed to natural microbes (NME) develop an appropriately mature immune system, one that resembles that of a non-neonatal human.1,2 Collagen induced arthritis is…
  • Abstract Number: 1434 • ACR Convergence 2022

    Retrospective Analysis of Tocilizumab-induced Neutropenia in Patients with Rheumatoid Arthritis

    YoungEun Kim1, Soo Min Ahn1, Ji Seon Oh2, Yong Gil Kim1, Chang Keun Lee1, Bin Yoo1 and Seokchan Hong1, 1Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Seoul, Republic of Korea, 2Department of Information Medicine, Big Data Research Center, Asan Medical Center, Seoul, Republic of Korea

    Background/Purpose: Neutropenia has been reported as one of the most frequent adverse events of tocilizumab. We conducted a retrospective cohort study to determine the risks…
  • Abstract Number: 0151 • ACR Convergence 2022

    Novel Innate Immunity Predictors of Infections in Idiopathic Inflammatory Myopathies Patients: A Cohort Study

    Diana Gómez-Martín1, jiram torres-Ruiz1, victor Hugo Tovar-Méndez2, Fabiola Cassiano-Quezada3, Daniel Alberto Carrillo-Vázquez4, Alfredo Pérez-Fragoso4, Nancy Mejía-Rodríguez5 and guillermo Juárez-Vega5, 1INCMNSZ, Ciudad de México, Mexico, 2Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 4Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 5Red de Apoyo a la Investigación. UNAM, Ciudad de México, Mexico

    Background/Purpose: Risk factors associated with the development of infections in patients with idiopathic inflammatory myopathies (IIM) have not been fully addressed, particularly those related to…
  • Abstract Number: 1476 • ACR Convergence 2022

    Anti-Neutrophil Extracellular Traps (NET) Antibodies and Their Association with Disease Activity and Clinical Phenotypes in Systemic Lupus Erythematosus

    Rosa Arvizu-Rivera1, jiram torres-Ruiz2, Alfredo Pérez-Fragoso2, Beatriz Alcalá-Carmona3, Miroslava Nuñez-Aguirre4, Ana Sofía Vargas-Castro4, Abdiel Absalón-Aguilar3, Jaquelin Lira-Luna4 and Diana Gómez-Martín2, 1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, Mexico, 2INCMNSZ, Ciudad de México, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Ciudad de México, Mexico

    Background/Purpose: Enhanced netosis has been acknowledged as pathogenic in Systemic Lupus Erythematosus (SLE). The presence of antibodies against neutrophil extracellular traps (anti-NETs) in patients with…
  • Abstract Number: 0491 • ACR Convergence 2022

    Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis

    Despina Michailidou1, Bhargavi Duvvuri1, Runa Kuley1, David Cuthbertson2, Peter Grayson3, Nader Khalidi4, Curry Koening5, Carol Langford6, Carol McAlear7, Larry Moreland8, Christian Pagnoux9, Philip Seo10, Ulrich Specks11, Antoine Sreih7, Kenneth J. Warrington11, Tomas Mustelin1, Paul Monach12, Peter Merkel13 and Christian Lood1, 1Division of Rheumatology, University of Washington, Seattle, WA, 2University of South Florida, Tampa, FL, 3National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4Division of Rheumatology, Mc Master University, Ontario, Canada, Ontario, Canada, 5Division of Rheumatology, University of Utah, Salt Lake City, UT, USA, Salt Lake City, UT, 6Cleveland Clinic, Cleveland, OH, 7Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA, 8University of Colorado, Denver, CO, 9Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, 10Johns Hopkins University, Baltimore, MD, 11Mayo Clinic, Rochester, MN, 12VA Boston Healthcare System, Boston, MA, 13University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Neutrophils contribute to the pathogenesis of many autoimmune diseases. The purpose of the study was to assess two markers of neutrophil activation, calprotectin and…
  • Abstract Number: 1545 • ACR Convergence 2022

    Increased Neutrophil Activation in Patients with Polymyalgia Rheumatica

    Despina Michailidou1, Linda Johansson2, Runa Kuley1, TING WANG1, Payton Hermanson1, Solbritt Rantapää-Dahlqvist2 and Christian Lood1, 1Division of Rheumatology, University of Washington, Seattle, WA, 2Department of Public Health and Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden

    Background/Purpose: Neutrophils are important in host defense. However, neutrophil activation has also been involved in the immunopathogenesis of several autoimmune diseases due to their many…
  • Abstract Number: 0537 • ACR Convergence 2022

    Neutrophil Extracellular Traps as a Biomarker to Predict Outcomes in Lupus Nephritis

    Laura Patricia Whittall Garcia1, Farnoosh Naderinavi1, Zahi Touma2, Dafna Gladman3, Murray Urowitz4, Anna Konvalinka1 and Joan Wither5, 1University Health Network, Toronto, ON, Canada, 2Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 3Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, ON, Canada, 4University of Toronto, University Health Network, Schroeder Arthritis Institute, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Neutrophil Extracellular Traps (NETs) have been implicated in Lupus Nephritis (LN) pathogenesis. SLE neutrophils release High Mobility Group Box-1 (HMGB1) protein, in turn, HMGB1…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology